A Post-Marketing Study Evaluating the Presence and Concentration of BRIUMVI®(ublituximab-xiiy) in Breastmilk (PROVIDE)

site-sidebar-layout : default
ast-site-content-layout : default
site-content-style : default
site-sidebar-style : default
theme-transparent-header-meta : default
stick-header-meta : default
Drug Category : Array
Conference Category : Array
Lead Author : Bove R. et al.
Published Date : 30/05/2025
Download Link : https://www.tgtherapeutics.com/wp-content/uploads/2024/05/TGTX-Lactation-Study-PROVIDE-CMSC-Bove-5.30.24.pdf
Download Text :
Popup Confirmation? :
astra-migrate-meta-layouts : set
Scroll to Top